All third-party trademarks and tradenames (including logos and icons) referenced are and remain the ... under its collaboration agreement with AstraZeneca. Working together, the companies utilized ...
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...
Barclays analyst Emily Field maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
Shares of AstraZeneca PLC AZN inched up 0.35% to £118.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.
Transformers One is here and the prequel film is unleashing plenty of Cybertronian secrets in its runtime. Focusing on the ...
AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations ...